Healthcare -
Biotechnology - NASDAQ - US
$ 1.045
-6.7 %
$ 119 M
Market Cap
-0.64
P/E
FATE - ACCOUNTS PAYABLE
Accounts Payable FATE - Fate Therapeutics, Inc.
4.72 M
LAST VALUE
-25.98%
2 YEAR CAGR
2.33%
5 YEAR CAGR
21.34%
10 YEAR CAGR